sub:provenance {
  sub:assertion dcterms:description "[In contrast to the nonsteroidal LXR agonist N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide (T0901317), 3alpha, 6alpha, 24-trihydroxy-24, 24-di(trifluoromethyl)-5beta-cholane (ATI-829), a novel potent synthetic steroidal LXR agonist, was a poor inducer of sterol regulatory element-binding protein 1c expression in hepatoma HepG2 cells, whereas both compounds increased ABCA1 expression in macrophage THP-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
    
wi:evidence dgn-void:source_evidence_literature ;
    
sio:SIO_000772 miriam-pubmed:18723776 ;
    
prov:wasDerivedFrom dgn-void:BEFREE ;
    
prov:wasGeneratedBy eco:ECO_0000203 . 
  
dgn-void:BEFREE pav:importedOn "2017-02-19"^^
xsd:date . 
  
dgn-void:source_evidence_literature a eco:ECO_0000212 ;
    
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
    
rdfs:label "DisGeNET evidence - LITERATURE"@en . 
}